Product overview
Vaccine type
Influenza, Pandemic (H1N1)
Commercial Name
NASOVAC Influenza Vaccine, Live Attenuated (Human) Freeze-Dried
Manofacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India
URL
Prequalification
Prequalification Status
Current: No Routine Production
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Vial + Ampoule
Number of Doses
1
Route of Administration
Intranasal
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 2
Secondary Packaging
a. Carton of 50 vials (active)(50 doses)[Dimensions 18.5x9.5x5.0 cm]; b.Carton of 50 vials (50 doses)(diluent) [Dimensions 18.5x9.5x5.0 cm] containing 0.5 mL Sterile Water for inahalation OR carton of 200 plastic ampoules (diluent) (40 cards of 5 ampoules) containing 0.5mL Sterile Water for Inhalation [Dimensions 23.5x15x9.5 cm]
Tertiary Packaging
a.Box of 24 cartons of 50 vials (active)(1200 vials/1200 doses) [Dimensions 60x48x41 cm]; b)Box of 24 cartons of 50 vials (diluent)(1200 vials/1200 doses) [dimension 39x32x23 cm] OR box of 6 cartons of 200 ampoules (1200 ampoules/1200 doses] [dimension 24.5x29.5x31.0 cm]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
17.575 cm3/dose (in secondary packaging)
Attachments
